Endava plc
NYSE:DAVASoftware - Infrastructure
-$0.10 today
- Market cap
- $75.88M
- Beta
- 1.04
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$7.98
Volume 0.27M
Average 0.34M
DAVA Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Endava plcNYSE: DAVA
Accounts Receivables · Q3 FY2026 · quarter ended Mar 2026
Accounts receivables outflow grows to £0
Q3 FY2026 accounts receivables was £0, compared with £0 a year earlier. Trailing-twelve-month accounts receivables was -£18.6M. Over 3 fiscal years it compounded at -20.5% a year.
Context
- Accounts receivables amounted to 2.4% of revenue in FY2025, up 1.7 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near £0 or moves back toward the trailing-twelve-month quarterly average of -£4.65M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
GBP · from the cash flow
- Latest · FY2025
- (18.6M) GBP
- Year-over-year change
- -436.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (18.6M) | -436.3% |
| FY2024 | 2024-06-30 | 5.53M | +240.5% |
| FY2023 | 2023-06-30 | (3.94M) | +89.4% |
| FY2022 | 2022-06-30 | (37.01M) | -89.7% |
| FY2021 | 2021-06-30 | (19.51M) | — |
Accounts Receivables vs competitors
How DAVA compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -436.3% is the 9th highest of 10, against a peer median of -44.3%.
- Accounts receivables amounts to 2.6% of revenue for DAVA, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
CLMBClimb Global Solutions, Inc. | LTM Mar 2026 | $56.81M USD | -7.1% | — | 8.2% |
| LTM Mar 2026 | £18.6M GBP | -436.3% | -20.5% | 2.6% | |
| LTM Mar 2026 | $15M USD | +33.9% | -47.5% | 3.1% | |
| LTM Mar 2026 | $13.69M USD | -650.8% | -33.3% | 1.7% | |
| LTM Mar 2026 | $9.57M USD | -44.3% | +25.7% | 1.5% | |
| LTM Mar 2026 | $8.82M USD | +328.7% | -19.8% | 3.6% | |
| LTM Mar 2026 | $8.53M USD | — | -52.5% | 1.7% | |
| LTM Mar 2026 | $6.93M USD | -46.6% | +3.7% | 0.7% | |
| LTM Mar 2026 | $2.49M USD | +1571.8% | +44.5% | 1.7% | |
| LTM Mar 2026 | $1.94M USD | -60.7% | -1.5% | 0.6% | |
| FY2025 | $715K USD | -121.2% | -65.8% | 134.9% | |
| Peer median (excluding DAVA) | — | -44.3% | -19.8% | 1.7% | |
Competitors are the stored peer set for DAVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 43.45M | 83.09M | 94.16M | 17.12M | 21.21M |
| Depreciation & Amortization | 24.45M | 28.97M | 32.93M | 38.94M | 44.94M |
| Deferred Income Tax | 8.28M | 17.08M | 20M | 2.07M | 2.44M |
| Stock-Based Compensation | 24.43M | 35.01M | 31.06M | 34.68M | 32.05M |
| Change in Working Capital | (21.36M) | (21.77M) | (16.07M) | (16.58M) | (40.19M) |
| Accounts Receivables | (19.51M) | (37.01M) | (3.94M) | 5.53M | (18.6M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (1.86M) | 15.24M | (12.14M) | (22.11M) | (21.58M) |
| Other Non-Cash Items | 8.43M | (21.65M) | (37.56M) | (21.84M) | (7.68M) |
| Operating Cash Flow | 87.67M | 120.72M | 124.52M | 54.39M | 52.77M |
| Capital Expenditures | (5.43M) | (13.97M) | (13.67M) | (5.49M) | (4.7M) |
| Acquisitions (Net) | (101.26M) | (10.36M) | (79.69M) | (236.11M) | (6.83M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 277K | 456K | (17.49M) | (48.73M) | 1.6M |
| Investing Cash Flow | (106.41M) | (23.88M) | (110.85M) | (290.33M) | (9.94M) |
| Debt Repayment | (11.26M) | (12.12M) | (11.37M) | 133.22M | 29.86M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (64.77M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (657K) | 7.04M | 375K | 1.84M | (10.23M) |
| Financing Cash Flow | (11.92M) | (5.08M) | (11M) | 135.06M | (45.13M) |
| Effect of Forex Changes | (781K) | 1.16M | (772K) | (1.47M) | (717K) |
| Net Change in Cash | (31.44M) | 92.92M | 1.9M | (102.35M) | (3.01M) |
| Free Cash Flow | 82.24M | 106.75M | 110.84M | 48.91M | 48.07M |
Endava plc
NYSE:DAVA
Intrinsic Alpha fair value
Locked
Current Price
$1.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.